Literature DB >> 24697532

Not too big, not too small: a goldilocks approach to sample size selection.

Kristine R Broglio1, Jason T Connor, Scott M Berry.   

Abstract

We present a Bayesian adaptive design for a confirmatory trial to select a trial's sample size based on accumulating data. During accrual, frequent sample size selection analyses are made and predictive probabilities are used to determine whether the current sample size is sufficient or whether continuing accrual would be futile. The algorithm explicitly accounts for complete follow-up of all patients before the primary analysis is conducted. We refer to this as a Goldilocks trial design, as it is constantly asking the question, "Is the sample size too big, too small, or just right?" We describe the adaptive sample size algorithm, describe how the design parameters should be chosen, and show examples for dichotomous and time-to-event endpoints.

Entities:  

Keywords:  Bayesian adaptive trial design; Predictive probabilities; Sample size; Sequential design

Mesh:

Year:  2014        PMID: 24697532     DOI: 10.1080/10543406.2014.888569

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  14 in total

1.  Bayesian clinical trials at The University of Texas MD Anderson Cancer Center: An update.

Authors:  Rebecca S Slack Tidwell; S Andrew Peng; Minxing Chen; Diane D Liu; Ying Yuan; J Jack Lee
Journal:  Clin Trials       Date:  2019-08-26       Impact factor: 2.486

2.  Design and rationale for the treating Obstructive Sleep Apnea using Targeted Hypoglossal Nerve Stimulation (OSPREY) trial.

Authors:  Ofer Jacobowitz; Alan R Schwartz; Eric G Lovett; Giovanni Ranuzzi; Atul Malhotra
Journal:  Contemp Clin Trials       Date:  2022-05-22       Impact factor: 2.261

3.  The utility of Bayesian predictive probabilities for interim monitoring of clinical trials.

Authors:  Benjamin R Saville; Jason T Connor; Gregory D Ayers; JoAnn Alvarez
Journal:  Clin Trials       Date:  2014-05-28       Impact factor: 2.486

4.  Clinical Trial Adaptation by Matching Evidence in Complementary Patient Sub-groups of Auxiliary Blinding Questionnaire Responses.

Authors:  Ognjen Arandjelović
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

5.  The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial: an adaptive trial design case study.

Authors:  Jason T Connor; Kristine R Broglio; Valerie Durkalski; William J Meurer; Karen C Johnston
Journal:  Trials       Date:  2015-03-04       Impact factor: 2.279

6.  Using Bayesian adaptive designs to improve phase III trials: a respiratory care example.

Authors:  Elizabeth G Ryan; Julie Bruce; Andrew J Metcalfe; Nigel Stallard; Sarah E Lamb; Kert Viele; Duncan Young; Simon Gates
Journal:  BMC Med Res Methodol       Date:  2019-05-14       Impact factor: 4.612

7.  Improving Lung Function in Severe Heterogenous Emphysema with the Spiration Valve System (EMPROVE). A Multicenter, Open-Label Randomized Controlled Clinical Trial.

Authors:  Gerard J Criner; Antoine Delage; Kirk Voelker; D Kyle Hogarth; Adnan Majid; Michael Zgoda; Donald R Lazarus; Roberto Casal; Sadia B Benzaquen; Robert C Holladay; Adam Wellikoff; Karel Calero; Mark J Rumbak; Paul R Branca; Muhanned Abu-Hijleh; Jorge M Mallea; Ravi Kalhan; Ashutosh Sachdeva; C Matthew Kinsey; Carla R Lamb; Michael F Reed; Wissam B Abouzgheib; Phillip V Kaplan; Gregory X Marrujo; David W Johnstone; Mario G Gasparri; Arturo A Meade; Christopher A Hergott; Chakravarthy Reddy; Richard A Mularski; Amy Hajari Case; Samir S Makani; Ray W Shepherd; Benson Chen; Gregory E Holt; Simon Martel
Journal:  Am J Respir Crit Care Med       Date:  2019-12-01       Impact factor: 21.405

8.  Do we need to adjust for interim analyses in a Bayesian adaptive trial design?

Authors:  Elizabeth G Ryan; Kristian Brock; Simon Gates; Daniel Slade
Journal:  BMC Med Res Methodol       Date:  2020-06-10       Impact factor: 4.615

9.  Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study.

Authors:  Jason T Connor; Bryan R Luce; Kristine R Broglio; K Jack Ishak; C Daniel Mullins; David J Vanness; Rachael Fleurence; Elijah Saunders; Barry R Davis
Journal:  Clin Trials       Date:  2013-08-27       Impact factor: 2.486

10.  Adding flexibility to clinical trial designs: an example-based guide to the practical use of adaptive designs.

Authors:  Thomas Burnett; Pavel Mozgunov; Philip Pallmann; Sofia S Villar; Graham M Wheeler; Thomas Jaki
Journal:  BMC Med       Date:  2020-11-19       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.